kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer KRAS mutation: from undruggable to
KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy KRAS OriGene Technologies Inc. Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS Screening and Profiling Services
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



